Pack Ventures, a new venture capital fund that is collaborating with the University of Washington, aims to help entrepreneurs launch new innovations and grow startups that emerge across the UW, while also giving Husky alumni access to investment opportunities.
The solution builds new mineral microlayers that penetrate deep into the tooth to create effective, long-lasting natural protection. It could provide easily accessible relief for the millions of adults worldwide who suffer from tooth sensitivity.
The UW School of Pharmacy’s Drug Interaction Database — the core research tool from the school’s nonprofit Drug Interaction Solutions team — is celebrating both a national award for innovation and two decades of independent funding through licensing agreements with companies, research institutes and regulatory agencies around the globe.
Creative Destruction Lab, a nonprofit organization for massively scalable, seed-stage, science- and technology-based companies, will launch its third U.S.-based location, CDL-Seattle, this fall. Based at the UW’s Foster School of Business, CDL-Seattle will be a partnership with Microsoft Corporation, the UW College of Engineering, Paul G. Allen School of Computer Science & Engineering and CoMotion, UW’s collaborative innovation hub. The initial area of focus for CDL-Seattle is computational health.
A commitment to innovation powered the University of Washington to a No. 7 ranking for graduate entrepreneurship programs by The Princeton Review. The 2021 ranking marks an all-time high — solidifying UW and the Foster School of Business as a leader in entrepreneurial education and incubation within the Pac-12 and across the Western United States.
With $4 million in matching funds from the National Institutes of Health, the University of Washington has created a new integrated center to match biomedical discoveries with the resources needed to bring innovative products to the public and improve health. “The University of Washington and regional partner institutions produce some of the most exciting biomedical discoveries and technologies in the world, but we always find it challenging to support their product development as they move into the early commercialization phases,”…
François Baneyx has been named Vice Provost for Innovation at the University of Washington, Provost Mark Richards announced yesterday at the inaugural meeting of the UW Innovation Roundtable. Baneyx was appointed Interim Vice Provost for Innovation in July 2019. Baneyx is also director of CoMotion, UW’s collaborative innovation hub dedicated to expanding the economic and societal impact of the UW community. In addition, he is the Charles W.H. Matthaei Professor of Chemical Engineering and an adjunct professor of Bioengineering, and…
François Baneyx has been named the new director of CoMotion and Interim Vice Provost of Innovation at the University of Washington, Provost Mark Richards announced today. Baneyx fills a position formerly held by Vikram Jandhyala, who died in March. “François is a respected researcher, teacher and innovator with connections throughout academia and industry, as well as firsthand experience with startups,” Richards said. “I am confident that with his interdisciplinary, collaborative approach to his work and leadership, François will build upon…
Researchers at the University of Washington are among the winners of a startup challenge to shorten the transition time from lab bench to patient. The team, including members of professor Suzie Pun’s research group in the UW Department of Bioengineering, was selected based on its proposal and business plan to develop a targeted drug delivery system for breast cancer.
Two University of Washington undergraduates have won a $10,000 Lemelson-MIT Student Prize for their “SignAloud” invention — gloves that can translate American Sign Language into text or speech.